anastrozole

Anastrozole was first approved for use in the United States in 1995.It is used in the treatment and prevention of breast cancer in women. Reference standards of Anastrozole API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => α,α,α’,α’-Tetramethyl-5-methyl-1,3-benzenediacetonitrile-d12
    [catalogue_number] => PA STI 082390
    [category_ids] => ,123,81,75,76,78,70,82,
    [chemical_name] => 
    [weight] => 238.4
    [form] => C15H6D12N2
    [cas] => 1185098-75-2
    [pslug] => 1185098-75-2-alpha-alpha-alpha-alpha-tetramethyl-5-methyl-1-3-benzenediacetonitrile-d12-pasti082390
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA STI 082390

α,α,α’,α’-Tetramethyl-5-methyl-1,3-benzenediacetonitrile-d12


  • Catalogue No.:PA STI 082390

  • CAS :

    1185098-75-2

  • Molecular Formula : C15H6D12N2

  • Molecular Weight : 238.4